Skip to content

SI-BONE, Inc. SIBN Operating Cash Flow

Operating Cash Flow at other companies

Stryker logo
StrykerSYK
$581M+132%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$359.4M-6.1%
Globus Medical logo
Globus MedicalGMED
$202.36M+14.1%
Alphatec Holdings logo
Alphatec HoldingsATEC
$1.29M+126%
Medtronic logo
MedtronicMDT
$2.57B+1.8%
IAR
Integra LifeSciencesIART
$9.8M+187%

Other financials

Income statement

See full
Revenue$52.6M+11.2%
Gross profit$41.9M+11.3%
Operating income-$5.1M+31.9%
Net income-$4.3M+33.8%
EPS (diluted)-$0.10+33.3%

Balance sheet

See full
Cash & equivalents$33.5M-18.6%
Total debt$42.9M+15.6%
Total equity$178.9M+7.0%
Total assets$242.7M+6.8%

Cash flow

See full
CapEx$1.1M-48.0%
Free cash flow-$3.4M+50.8%

Valuation

See full
Market cap$743.29M+6.4%
Enterprise value$752.71M+8.4%
P/S3.6×-0.4×

Profitability

See full
Gross margin79.6%+0.3pp
Operating margin-9.7%-3.0pp
Net margin-8.1%-2.6pp
FCF margin-2.9%-1.2pp

Returns & leverage

See full
Return on equity-9.6%-2.7pp
Debt / equity0.2×0.0×
Current ratio10×+1.5×

Where this comes from

Reported directly by SI-BONE, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: SI-BONE, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about SI-BONE, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SI-BONE, Inc.'s operating cash flow?
SI-BONE, Inc. (SIBN) reported operating cash flow of -$2.36M in Q1 2026.
How has SI-BONE, Inc.'s operating cash flow changed year-over-year?
SI-BONE, Inc.'s operating cash flow increased by 51.9% year-over-year, from -$4.91M to -$2.36M.
What is the long-term trend for SI-BONE, Inc.'s operating cash flow?
Over 2 years (2021 to 2023), SI-BONE, Inc.'s operating cash flow has grown at a -31.2% compound annual growth rate (CAGR), from -$39.53M to -$18.71M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.